Acumen Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 14.93 M | $37.03 M | 0.00% | 24.85% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 3.55 M | $8.34 M | 5.39% | 5.91% |
| SANDS CAPITAL VENTURES, LLC | 11/13/2024 | 3.42 M | $8.47 M | 0.00% | 5.69% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.33 M | $5.78 M | 100.00% | 3.88% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 2.30 M | $5.70 M | 0.00% | 3.83% |
| FMR LLC | 11/13/2024 | 2.03 M | $5.03 M | 0.30% | 3.38% |
| VANGUARD GROUP INC | 11/13/2024 | 1.93 M | $4.80 M | 1.96% | 3.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.83 M | $4.55 M | -6.11% | 3.05% |
| KNOLLWOOD INVESTMENT ADVISORY, LLC | 11/14/2024 | 1.63 M | $4.04 M | 0.00% | 2.71% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 939,603 | $2.33 M | 0.00% | 1.56% |
| LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 867,046 | $2.15 M | -26.42% | 1.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 864,528 | $2.14 M | 6.45% | 1.44% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 849,619 | $2.11 M | -18.80% | 1.41% |
| JANE STREET GROUP, LLC | 11/15/2024 | 678,000 | $1.68 M | 100.00% | 1.13% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 636,000 | $1.58 M | -5.07% | 1.06% |
| PATHSTONE HOLDINGS, LLC | 11/07/2024 | 517,283 | $1.28 M | 7.72% | 0.86% |
| STATE STREET CORP | 11/14/2024 | 516,406 | $1.28 M | 18.29% | 0.86% |
| JANE STREET GROUP, LLC | 11/15/2024 | 487,596 | $1.21 M | 14.01% | 0.81% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 469,100 | $1.16 M | 19.64% | 0.78% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 309,507 | $767,577 | -0.42% | 0.52% |
| NORTHERN TRUST CORP | 11/13/2024 | 308,850 | $765,948 | 340.66% | 0.51% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 306,100 | $759,128 | -9.46% | 0.51% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 266,435 | $660,759 | 0.00% | 0.44% |
| MORGAN STANLEY | 11/14/2024 | 239,200 | $593,215 | 172.41% | 0.40% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 145,861 | $361,736 | 185.71% | 0.24% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 139,206 | $345,231 | -6.45% | 0.23% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 138,724 | $344,036 | 13.04% | 0.23% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 137,400 | $340,752 | -7.41% | 0.23% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 122,589 | $304,021 | -1.95% | 0.20% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 108,743 | $269,683 | 0.00% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 92,983 | $230,598 | -26.45% | 0.15% |
| CATALYST FINANCIAL PARTNERS LLC | 10/28/2024 | 89,699 | $222,454 | 0.00% | 0.15% |
| RHUMBLINE ADVISERS | 11/12/2024 | 88,484 | $219,434 | 69.11% | 0.15% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 82,702 | $205,101 | 9.01% | 0.14% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 78,446 | $194,546 | 38.44% | 0.13% |
| JPMORGAN CHASE & CO | 12/26/2024 | 63,066 | $156,404 | 252.78% | 0.11% |
| BARCLAYS PLC | 11/19/2024 | 61,997 | $154,000 | 189.08% | 0.10% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 56,556 | $140,259 | 0.01% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 54,800 | $135,904 | -65.66% | 0.09% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 54,543 | $135,267 | 20.02% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 54,019 | $133,967 | -0.11% | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 52,417 | $129,994 | 12.94% | 0.09% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 52,333 | $129,786 | -12.77% | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 51,708 | $128,236 | -39.49% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 49,500 | $122,760 | 52.31% | 0.08% |
| INTREPID FINANCIAL PLANNING GROUP LLC | 11/04/2024 | 30,150 | $74,772 | 0.00% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 23,015 | $57,077 | 100.00% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 22,751 | $56,423 | 77.94% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 22,429 | $55,624 | -0.61% | 0.04% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 22,255 | $55,000 | -8.80% | 0.04% |
Acumen Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 91 institutional investors and hedge funds held shares of Acumen Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Fortitude Advisory Group L.L.C.: 0
RA CAPITAL MANAGEMENT, L.P.: 14.93 M
FRANKLIN RESOURCES INC: 3.55 M
Sands Capital Ventures, LLC: 3.42 M
BlackRock Funding, Inc. /DE: 2.33 M
Rock Springs Capital Management LP: 2.3 M
72.58% of Acumen Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46.40 M shares in the last 24 months. This purchase volume represents approximately $76.10 M in transactions.